https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Zhonghua Xue Ye Xue Za Zhi 2005 Oct;26(10):593-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Zhonghua Xue Ye Xue Za Zhi 2005 Oct;26(10):593-72005-10-01 00:00:002019-02-15 08:51:02[In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-01-01 / Methods Mol. Med. 2005;109:127-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-01-01 / Methods Mol. Med. 2005;109:127-362005-01-01 00:00:002019-02-15 08:51:03Dendritic cells in clinical trials for multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-07-01 / Leuk. Lymphoma 2004 Jul;45(7):1419-28
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-07-01 / Leuk. Lymphoma 2004 Jul;45(7):1419-282004-07-01 00:00:002019-02-15 08:51:04Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-05-01 / Br. J. Haematol. 2004 May;125(3):343-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-05-01 / Br. J. Haematol. 2004 May;125(3):343-522004-05-01 00:00:002019-02-15 08:51:06Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-03-01 / J. Exp. Clin. Cancer Res. 2004 Mar;23(1):9-13
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-03-01 / J. Exp. Clin. Cancer Res. 2004 Mar;23(1):9-132004-03-01 00:00:002019-02-15 08:51:05Accomplishments and perspectives of immunological interventions in lymphoproliferative disorders
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Cytotherapy 2004;6(1):62-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Cytotherapy 2004;6(1):62-72004-01-01 00:00:002019-02-15 08:51:06DC-based immunotherapy of B-cell malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Leuk. Lymphoma 2003 Dec;44(12):2031-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Leuk. Lymphoma 2003 Dec;44(12):2031-82003-12-01 00:00:002019-02-15 08:51:25Dendritic cell-based immunotherapy in multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-10-01 / Haematologica 2003 Oct;88(10):1139-49
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-10-01 / Haematologica 2003 Oct;88(10):1139-492003-10-01 00:00:002019-02-15 08:51:07Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-04-01 / Hematology 2003 Apr;8(2):97-104
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-04-01 / Hematology 2003 Apr;8(2):97-1042003-04-01 00:00:002019-02-15 08:32:45Dendritic cell-based immunotherapy for the treatment of hematological malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-09-01 / Haematologica 2002 Sep;87(9):989-1001
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-09-01 / Haematologica 2002 Sep;87(9):989-10012002-09-01 00:00:002019-02-15 08:51:09Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines
